21 CFR 878.4675
§ 878.4675 Breast implant suction retrieval system.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 878.4675, § 878.4675 Breast implant suction retrieval system, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/90448
- Permanent ID
ys:prov:90448@1- SHA-256
1a8ddad2697c098dd09a5fb5071b6ace397a29fbd6c227de506ced4c89f83c33
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Identification. A breast implant suction retrieval system is a prescription surgical device that uses vacuum suction to assist in the removal and containment of a ruptured silicone breast implant.
(b) Classification. Class II (special controls). The special controls for this device are:
(1) Animal performance testing must demonstrate that the device performs as intended and will not result in tissue injury. Testing must:
(i) Demonstrate the ability to remove implants of the sizes and types specified in device labeling; and
(ii) Assess tissue integrity and injury at multiple time intervals to assess tissue healing response after device use.
(2) Non-clinical performance testing must demonstrate that the device performs as intended under anticipated conditions of use, including the following:
(i) Characterization of the range of device operation, including minimum and maximum vacuum suction parameters;
(ii) Durability and integrity testing; and
(iii) Characterization of control and variation of suction application.
(3) Performance testing must demonstrate the sterility of the device.
(4) Performance testing must support the shelf life of the device by demonstrating continued sterility, package integrity, and device functionality over the identified shelf life.
(5) The tissue-contacting components of the device must be demonstrated to be biocompatible.
(6) Usability testing must demonstrate that intended users can correctly use the device, based solely on reading the directions for use.
(7) Labeling must include the following:
(i) Summary of device specifications, including vacuum suction pressure ranges and bottle capacity; and
(ii) Sizes and types of implants that can be removed with the device.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.